Dashboard
1
Poor long term growth as Net Sales has grown by an annual rate of -3.78% and Operating profit at -141.55% over the last 5 years
- INTEREST(HY) At CNY 1.19 MM has Grown at 282.77%
- NET PROFIT(Q) At CNY -0.68 MM has Fallen at -108.1%
- OPERATING PROFIT(Q) Lowest at CNY -4.87 MM
2
Below par performance in long term as well as near term
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-8.14%
0%
-8.14%
6 Months
-11.8%
0%
-11.8%
1 Year
-8.28%
0%
-8.28%
2 Years
36.99%
0%
36.99%
3 Years
-6.3%
0%
-6.3%
4 Years
-25.6%
0%
-25.6%
5 Years
0%
0%
0.0%
Hangzhou Coco Healthcare Products Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-3.78%
EBIT Growth (5y)
-141.55%
EBIT to Interest (avg)
25.77
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.33
Sales to Capital Employed (avg)
0.65
Tax Ratio
8.08%
Dividend Payout Ratio
60.40%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.94%
ROE (avg)
7.42%
Valuation key factors
Factor
Value
P/E Ratio
110
Industry P/E
Price to Book Value
2.69
EV to EBIT
-1022.14
EV to EBITDA
50.27
EV to Capital Employed
3.62
EV to Sales
2.86
PEG Ratio
1.28
Dividend Yield
0.20%
ROCE (Latest)
-0.35%
ROE (Latest)
2.45%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
Sep'25
Jun'25
Change(%)
Net Sales
280.50
266.70
5.17%
Operating Profit (PBDIT) excl Other Income
-4.90
15.90
-130.82%
Interest
0.80
0.40
100.00%
Exceptional Items
0.40
1.90
-78.95%
Consolidate Net Profit
-0.40
10.00
-104.00%
Operating Profit Margin (Excl OI)
-17.40%
-3.00%
-1.44%
USD in Million.
Net Sales
QoQ Growth in quarter ended Sep 2025 is 5.17% vs -4.10% in Jun 2025
Consolidated Net Profit
QoQ Growth in quarter ended Sep 2025 is -104.00% vs -46.24% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,076.90
1,077.70
-0.07%
Operating Profit (PBDIT) excl Other Income
58.50
60.60
-3.47%
Interest
1.50
1.40
7.14%
Exceptional Items
2.20
-13.40
116.42%
Consolidate Net Profit
30.60
17.80
71.91%
Operating Profit Margin (Excl OI)
-4.30%
-0.90%
-0.34%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -0.07% vs -9.08% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 71.91% vs 131.67% in Dec 2023
About Hangzhou Coco Healthcare Products Co., Ltd. 
Hangzhou Coco Healthcare Products Co., Ltd.
FMCG
No Details Available.
Company Coordinates 
No Company Details Available






